SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Kirk's Market Thoughts
COHR 158.81-4.7%12:07 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Winfastorlose who wrote (8673)3/26/2020 11:14:20 AM
From: Kirk ©1 Recommendation

Recommended By
Winfastorlose

   of 26452
 
Yup, loads of good news and reasons for optimism.

I believe Generic Hydroxycholoquine has been limited to patients who need it for rheumatoid arthritis and is very difficult to get... so the patients who really need it can have it until Bayer and others can ramp up the supply.

By the time the supply is ready, hopefully the science to back FDA approval to use it prophylactically is also ready and they can send us pills via the mail.

Realistically, they probably delay sending us pills in the mail until they have reams of data, but they can hopefully open up the economy when they have solid data showing this is a good treatment and our death rate stops dead just as the death rate in China from the virus did.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News